Lung Cancer Circle of Hope

02/06/2026

https://oncodaily.com/oncolibrary/biomarkers-in-lung-cancer

A bibliometric and visualization analysis of immunotherapy biomarkers in lung cancer (2001–2025), highlighting global research trends, multi-omics integration, ctDNA, microbiome, and AI-driven precision oncology.

02/06/2026

https://aacrjournals.org/cancerdiscovery/article-abstract/doi/10.1158/2159-8290.CD-RW2026-018/774190/High-Plasticity-Cell-State-Drives-Lung-Cancer?redirectedFrom=fulltext

A growing body of literature supports that phenotypic plasticity is associated with disease progression and therapeutic resistance, but whether specific, highly plastic states are functionally required in vivo remains unresolved. Chan, Pan, and colleagues developed mouse models of KrasG12D-mutant, T...

02/05/2026

https://www.scientificamerican.com/article/lung-cancer-hijacks-the-brain-to-trick-the-immune-system/

Lung cancer tumor cells in mice communicate with the brain, sending signals to deactivate the body’s immune response, a study finds

02/04/2026

https://www.cancernursingtoday.com/post/two-decades-of-data-reveal-mortality-patterns-disparities-in-lung-cancer-and-diabetes

The highest AAMRs were seen in 2005 among non-Hispanic Black patients, followed by non-Hispanic White patients and patients who identified as non-Hispanic “other."

02/03/2026

https://www.aacr.org/patients-caregivers/progress-against-cancer/fda-approves-subcutaneous-formulation-of-egfr-targeted-therapy-for-non-small-cell-lung-cancer/

FDA approved amivantamab and hyaluronidase-lpuj for subcutaneous injection to treat certain cases of EGFR-mutated non-small cell lung cancer.

02/03/2026

02/02/2026

https://www.news-medical.net/news/20260131/Additional-lymph-node-evaluation-needed-during-surgery-to-accurately-identify-lung-cancer-spread.aspx

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to accurately identify cancer spread.

02/01/2026

https://www.curetoday.com/view/actively-recruiting-trials-for-lung-biliary-aml-and-small-cell-cancer

Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; studies are currently enrolling.

01/30/2026

https://news.cuanschutz.edu/department-of-surgery/new-imaging-technologies-lung-cancer

Lung surgeons in the Division of Cardiothoracic Surgery employ advanced imaging technology such as Cytalux and Ceevra to help guide their operations.

01/29/2026

https://pubs.rsna.org/doi/10.1148/radiol.253004

Reviews and CommentaryEditorialJan 27 2026Lung Cancer in Patients Who Never Smoked: A Growing Health Care ConundrumAuthors: Cornelia Schaefer-Prokop, MD, PhD https://orcid.org/0000-0002-3394-2980 [email protected], and Mathias Prokop, MD, PhD https://orcid.org/0000-0001-8157-8055Authors Info & Affi...

01/28/2026

https://www.technologynetworks.com/analysis/news/scientists-uncover-new-clues-on-lung-cancer-treatment-resistance-408945

Researchers visualized ALK fusion proteins in real time. They showed that ALK inhibitors reshape flexible protein regions to suppress cancer signalling. Drug-resistant mutations prevent structural changes, explaining why treatment may fail.

01/27/2026

https://www.ama-assn.org/public-health/chronic-diseases/demystifying-new-tool-early-lung-cancer-detection

Bayhealth’s mobile classroom lets students and neighbors explore Ion robotic bronchoscopy, boosting awareness, screening and career interest.